B

BARD1 Life Sciences Ltd (ASX: BD1)

21 employees

Developing diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases.

Basic info

Industry

biotechnology research

Sectors

Life Sciences
Cancer Biomarkers
Diagnostics
Cancer Diagnostics
Extracellular Vesicles
Development
Exosomes

Date founded

2016

FAQ